Welcome to Crene Biotechnology!

+86-576-88205808

Product :

MBX-2982

MBX-2982 1037792-44-1
Size Price Stock Quantity
Get Quotation Now Add to Cart Bulk Inquiry
Shipping and handling fee USD40, Free delivery is qualified when the total value of your order exceeds USD500.If the item is temporarily out of stock. Please email to order@pharm-intermediates.com,we will inform you when we have it in stock.
Chemical Information
Product name:MBX-2982 Purity:98% min
CAS NO:1037792-44-1 Solubility:DMSO : 50 mg/mL (111.47 mM)
Molecular Formula:C22H24N8OS Package:Package according to customer requirements
Molecular Weight:448.544 Storage:Store at -20℃
Quality control
Remarks

MBX-2982, also known as SAR-260093, is a potential first-in-class treatment for type 2 diabetes that targets G protein-coupled receptor 119 (GPR119), a receptor that interacts with bioactive lipids known to stimulate glucose-dependent insulin secretion. Preclinical data indicate that MBX-2982 is a potent selective orally-active GPR119 agonist that functions through a unique dual mechanism of action. First, it acts directly on the beta cell to increase insulin secretion. In addition, MBX-2982 stimulates release of the incretin GLP-1 from the gut. This dual action is unique and may offer improved glucose homeostasis over existing diabetes therapies, with potential for weight loss and improved islet health.

 

Properties:

Boiling point: 683.6±65.0 °C(Predicted)

density: 1.42

pka: 5.39±0.42(Predicted)

 

 

 

GPR119 Related Products:

GSK1292263; APD668; AR231453

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.
Friendly link:

Copyright Copyright (C) 2018-2024 Taizhou Crene Biotechnology Co.,Ltd.  

Address:Economic Developed Zone of Taizhou Zhejiang China